• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Donor Deferral Model Evaluates Impact of New Individual Risk Assessment

When AIDS emerged in the early 1980s, the risk of acquiring HIV from a transfusion was approximately 1.1%. The U.S….

June 28, 2024

Liberal versus Restrictive Transfusion Strategy for Patients with Traumatic Brain Injury and Anemia

While a restrictive RBC transfusion strategy has been shown to be safe and effective for most patients, there is uncertainty…

June 19, 2024

Luspatercept Reduces Transfusion-Dependence for Anemic Patients with Myelofibrosis

Myelofibrosis is a rare bone marrow cancer characterized by excessive scarring that disrupts the production of red blood cells. Current…

June 11, 2024

FDA: Donor Screening of Zika Virus Unnecessary in United States

In 2015 and 2016, large outbreaks of the mosquito-borne Zika virus occurred in the Americas.  Infection with the Zika virus…

June 5, 2024

Tranexamic Acid Treatment Does Not Reduce Hematoma Growth in Patients with Intracerebral Hemorrhage

Intracerebral hemorrhage affects approximately 3.4 million individuals worldwide annually. Hematoma growth during intracerebral hemorrhage is associated with significant morbidity and…

May 29, 2024

Cold-Stored Platelets Do Not Restore Platelet Function as well as Room-Temperature Platelets

The U.S. Food and Drug Administration recently approved cold storage of platelets for up to 14 days for the treatment…

May 22, 2024

Recombinant ADAMTS13 Treatment for Congenital Thrombotic Thrombocytopenic Purpura

Congenital thrombotic thrombocytopenic purpura (TTP) is a rare disease caused by a severe hereditary deficiency of ADAMTS13, which normally cleaves…

May 15, 2024

Study Finds No Association Between RBC Transfusions and Necrotizing Enterocolitis

Necrotizing enterocolitis (NEC) affects approximately 1 in 1000 premature babies, usually two to six weeks after birth, and accounts for…

May 7, 2024

Gut Microbe Exoglycosidases Target ABO Blood Group Antigens to Generate ABO-Universal Blood

The ABO blood group is the most immunogenic group of blood antigens, and incompatible mismatched ABO-blood is among the most…

May 1, 2024

Increasing Data Available for Plasma Transfusion Indications

Plasma transfusions are often used to prevent and/or treat bleeding and to control blood volume in patients with trauma or…

April 23, 2024

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Interim pages omitted …
  • Page 62
  • Go to Next Page »

Primary Sidebar

Latest News

  • Array-based, comprehensive genotyping for erythroid, platelet, neutrophil and leukocyte antigens

  • Acute Normovolemic Hemodilution Does Not Reduce RBC Transfusions

  • Blood Donation Teams—a Novel Strategy to Support Novice Donors

  • Plasma Exchange to Reduce Biological Age

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley